BSEBoard Meeting3 Nov 2026 · 3 Nov 2026, 07:10 pm

Outcome of the Board Meeting pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 held on Tuesday, November 03, 2026

Deepak Chemtex Ltd · 544036

✦ AI SummaryResults

Deepak Chemtex Ltd has announced its unaudited financial results for the half year ended September 30, 2026, with the Board of Directors approving the results and the Limited Review Report of the Statutory Auditors.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Deepak Chemtex Ltd - 544036 - Board Meeting Outcome for Meeting Held On November 03, 2026

Attachments (1)

📄

2f2d6800-9ea6-4d90-8155-8c50c79aa901.pdf

pdf

Download →
View document text
November 3, 2026 BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai- 400 001 Scrip code: 544036 Subject: Intimation pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) - Outcome of the Board Meeting - Financial Results Dear Sir/Madam, Pursuant to Regulations 30 and 33 of the SEBI Listing Regulations, please take note that the Board of Directors of the Company has, at its Meeting held today i.e., November 3, 2026, considered and approved, inter-alia, the Un-audited Financial Results (standalone and consolidated) of the Company for the half year ended September 30, 2026 along with the Limited Review Report of the Statutory Auditors thereon. The said results along with the Limited Review Report is annexed herewith. The above information is also available on the website of the Company i.e., www.deepakchemtex.in The Board Meeting commenced at 06:00 p.m. and concluded at 06:15 p.m. Please take the same on your records. Thanking you, Yours faithfully, For Deepak Chemtex Limited Saurabh Deepak Arora Managing Director DIN: 00404150 Email id: saurabh@deepakchemtex.in MITTAL & ASSOCIATES 603, Raylon Arcade, RK Mandir Road, CHARTERED ACCOUNTANTS Kondivita, JB nagar Andheri (East), Mumbai – 400059 Tel : 8689958800 Email : audit@mittal-associates.com Independent Auditor's Review Report on the Unaudited Standalone Financial Results of DEEPAK CHEMTEX LIMITED pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 as amended The Board of Directors DEEPAK CHEMTEX LIMITED 1. We have reviewed the accompanying Statement of Unaudited Standalone Financial Results of DEEPAK CHEMTEX LIMITED ("the Company"), for the half year ended 30th September, 2026 ("the Statement"), being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (hereinafter referred to as “Listing regulations”). 2. The Company’s management is responsible for the preparation of the Statement in accordance with the recognition and measurement principles laid down in Accounting Standard 25 “Interim Financial Reporting” prescribed under section 133 of the companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The Statement has been approved by the Company’s Board of Directors. Our responsibility is to issue a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing and consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with applicable Accounting Standards (AS) and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. Mittal & Associates FRN: 106456W CA Sourabh Bagaria Partner M. No: 183850 UDIN: 26183850PKHUIH6534 Date: 3rd November, 2026 Place: Mumbai DEEPAK CHEMTEX LIMITED Address : Aawashi, 28/1A, A/P Adgul Aawashi, Lote, Ratnagiri Ratnagiri MH 415722 IN CIN : L24110PN1997PLC211935 STANDALONE BALANCE SHEET AS AT SEPTEMBER 30TH, 2026 (% in lakhs) Unless otherwise specified ‘As at September 30, 2026 As at March 31, 2026 Particulars (Unaudited) (Audited) Equity & Liabilities Shareholders funds: Share Capital 1.086.40 1.086.40 Reserves and Surplus 5.300.55 4.925.04 Money received against Share Warrants . . Share Application Money Pending Allotment - - Non-Current liabilities: Long-Term Borrowings 3397 49.06 Long Term Provisions 17.41 12.21 Current Liabiliti Short Term Borrowings 271.53 21.02 Trade Payables (1) Total Outstanding Dues of Micro & Small Enterprises 429.79 150.55 (u)"[ otal Outstanding Dues of Creditors Other Than Micro 98.34 7911 & Small Enterprises Other Current Liabilities 81.05 101.45 Short Term Provisions 44.00 3267 Total Equity & Li s 7,363.05 6,458.11 Assets Non-Current Assets: Property, Plant & Equipment and Intangible Assets (i) Property, Plant & Equipment 83403 733.98 (i) Intangible Assets 9.28 11.54 (i) WIP 149.46 66.60 Non-Current Investments 9.82 9.82 Deflered Tax Assets 6586 52.97 Long Term Loans and Advances 2,553.05 2,250.27 Other Non-Current Assets 539.30 564.56 Current Assets: Current Investments i - Inventories 1.040.12 831.14 Trade Receivables 1.553.61 1.374.22 Cash and Cash Equivalents 307.71 32374 Short Term Loans and Advances : 192.22 8797 Other Current Assets 108.58 15131 Total Assets 7,363.05 6,458.11 For and on behaloff Board of Directors| Trishla Baid Date : 3rd November, 2026 Place : Mumbai DIN:07063446 Director & Chief Financial Officer DEEPAK CHEMTEX LIMITED Address : Aawashi, 28/1A, A/P Adgul Aawashi, Lote, Ratnagiri Ratnagiri MH 415722 IN CIN : L24110PN1997PLC211935 STATEMENT OF STANDALONE RESULT FOR THE PERIOD ENDED 30TH SEPTE (M B inE lR a, 2 s0 2 U6 n less otherwise specified THalf Vear Ended Vear Ended September 30, September 30, March 31,/ March 31, earticul 2026 2025 2026 2026 (Unaudited) | (Unaudited) | (Audited) | (Audited) 325427 269878 | 265083 534961 Revenue from Operations 177.14 7973 | 21927 299.00 Other Incomes 343141 2,778.51 | 287010 | 564861 “Total Income (1) Expenses 2.209.55 191673 | 132322 3.240.05 Cost of Raw Materials Consumed 159.96 15582 | 47934 635.16 Purchases of stock in Trade (75.97) @4770)| 4902 (198.68) Change in Inventories 198.17 17066 | 21335 384.01 Employee Benefits Expenses 829 428 6.10 10.38 Finance Costs 6572 7155 7552 147.07 Depreciation Other Expenses 2,3 9R 58 27 .. 80 18 232 36 75 .. 18 95 242 171 8. 37 27 475 537 5. 66 12 ‘Total Expenses (11) l)::»om before Exceptional & Extraordinary items and Tax (I- e N s Ry . = : . Ixceptional Items 478.60 4132 45178 893.00 Profit before Extraordinary items and tax - - - Extraordinary items 178.60 44132 | 45178 893.00 Profit before tax “Tax Expense 116.58 10871 1L7S 22046 Current Tax S P B e Earlier Year Tax (12.89) 039 2367 13.28 Deferred Tax Expenses 37491 342.99 | 31633 659.26 Profit for the period from Continuing Operations Profit from Discontinuing Operations Tax Expense of Discontinuing Operations 37491 342.99 | 31635 659.26 Profit for the period T Earning per share 345 316 281 597 Basic (in Rs) 3.45 316 281 597 Diluted (in Rs) For and on behalf of Board of Directors| Trishla Baid Date : 3rd November, 2026 DIN:07063446 Place : Mumbai Director & Chief Financial Officer DEEPAK CHEMTEX LIMITED Address : Aawashi, 28/1A, A/P Adgul Aawashi, Lote, Ratnagiri Ratnagiri MH 41 5722 IN CIN : L24110PN1997PLC211935 STANDALONE CASHFLOW STATEMENT FOR THE PERIOD ENDE:! D ( %O iN n lS aE khP sT ) E UM nlB eE ssR , ot 3 he0 rT wH i, s e2 0 sp2 e6 c ified For the period ended on For the period ended on Particulars September 30th, 2026 September 30th, 2025 Cash Flow From Investing A 478.60 44131 Net Profit before ta [Showing first 8,000 characters — download PDF for full document]